In this episode, we explore key developments in the global life sciences and biotech sectors. Telangana is set to unveil its Next-Generation Life Sciences Policy 2026–2030 at the World Economic Forum, aiming to position itself as a top global life sciences hub. The U.S. biotech sector faces challenges from inconsistent funding and regulations, risking its global leadership. Lilly and NVIDIA announce a $1 billion AI-focused co-innovation lab in South San Francisco, while Illumina launches the Billion Cell Atlas to enhance AI-driven drug discovery. Hippocratic AI acquires Grove AI to boost its life sciences capabilities. Changes to the UK's Voluntary Pricing and Access Scheme are underway following a UK-US trade deal. Lastly, Rosanna Zhang from ACROBiosystems discusses the use of organoids in neuroscience research, offering new insights into brain disorders.

Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture.

As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics.

Start your VoiceStream free trial today!